Premium
Health Care Competition and Antibiotic Use in T aiwan
Author(s) -
Bennett Daniel,
Hung CheLun,
Lauderdale TsaiLing
Publication year - 2015
Publication title -
the journal of industrial economics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.93
H-Index - 77
eISSN - 1467-6451
pISSN - 0022-1821
DOI - 10.1111/joie.12075
Subject(s) - antibiotics , competition (biology) , percentile , antibiotic resistance , health care , medicine , population , public health , environmental health , intensive care medicine , economics , statistics , microbiology and biotechnology , biology , nursing , economic growth , ecology , mathematics
Antibiotic resistance, a negative externality of antibiotic use, is a growing threat to public health. Health care competition may encourage antibiotic use because receiving an antibiotic is a form of ‘quality’ for many patients. This paper examines the effect of market concentration on antibiotic use in a large, nationally‐representative data set from T aiwan. Moving from the 75th percentile to the 25th percentile of market concentration is associated with 6.6 per cent greater antibiotic use. We control for leading market‐level confounds, including population density and community health. We also show that the correlation is robust using fixed effects for patients, physicians and diagnoses. We document the correlation between antibiotic use and patient retention, which suggests a mechanism for this result. Finally, we show that strict regulation of antibiotics reduces but does not eliminate the effect of competition on antibiotic use.